Transcript EUnetHTA Joint Action 2010-2012, Iris Pasternack

EUnetHTA Joint action 2010-2012
Sharing expertise and efforts
Iris Pasternack, research officer, FINOHTA
European Patients’ Forum Spring Seminar on HTA
18 May 2010 Brussels
EUnetHTA Joint Action 2010–2012 | www.eunethta.eu
What is EUnetHTA?
•
•
•
•
European network for HTA
2006-2008 EUnetHTA project
2009 EUnetHTA Collaboration
2010-2012 Joint Action between European
Commission and EU Member States
– A total of 33 government appointed organisations
from 23 EU Member States and Norway and a large
number of relevant regional agencies and non-forprofit organisations that produce or contribute to
HTA
2
EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu
Joint Action 2010–2012
A Venn Diagram to illustrate the transition from EUnetHTA
Project Associate Partnership to EUnetHTA Collaboration
Founding Partnership to Joint Action Associate Partnership
Partner
Partner
EUnetHTA
Partner
Collaboration Partner
Founding Partners
Partner
Partner
Partner
Partner
Partner
Partner
EUnetHTA Project
Associated Partners
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
Partner
EUnetHTA
Joint Action
Associated Partners
Partner
Partner
3
EUnetHTA | European network for Health Technology Assessment | www.eunethta.net
EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu
Joint Action 2010–2012
Why EUnetHTA?
• Double work could be avoided
– Example: cancer drugs
• Relevance of HTA can be improved
– Example: patient perspective in surgery for
severe obesity
• Quality of HTA can be improved
– Example: pool of experts
4
EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu
Joint Action 2010–2012
Plenary Assembly
(policy setting)
reporting
EU Institutions
info
Executive Committee
(strategic planning of activities) info
reporting
coordination /
exchange of
info
5
control
Determine
activities
Stakeholder
Forum
control
Secretariat
reporting
support/control
Work
Work
Work
Work
Work
Work
Work
Work
Package
Package
Package
Package
Package
Package
Package
Package
EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu
Joint Action 2010–2012
What is HTA Core Model?
• An online-tool for HTA-developers
• Contains
– structure for HTA generation and reporting
– advice on methodologies
• What is new? Information is split into
elements
6
EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu
Joint Action 2010–2012
Domains of the HTA Core Model
1. Health problem and current use of technology
2. Description and technical characteristics
3. Safety
4. Clinical effectiveness
5. Costs and economic evaluation
6. Ethical analysis
7. Organisational aspects
8. Social aspects
9. Legal aspects
7
EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu
Joint Action 2010–2012
Social aspects
Which social areas does the use of the technology influence?
Topic 1: Major life areas
Who are the important others that the use of the technology
may affect in addition to the patient?
What kind of support and resources are needed or might be
released as the technology is put to use?
What kinds of changes does the use of the technology generate
in the patient's role in the major life areas?
Topic 2: Individual
What kind of changes does the implementation and use of the
technology mean for the patients physical and psychological
functioning in his or her major life areas?
How do patients and important others react and act upon the
technology?
What is patients' and important others’ knowledge and
understanding of the technology?
Topic 3: Communication
How is the information regarding the use of the technology
processed and exchanged?
What are the consequences in decision making?
8
EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu
Joint Action 2010–2012
Social aspects
Topic 1: Major life areas
Issue 1: Which social areas does the use of the technology
influence?
Issue 2: Who are the important others that the use of the technology
may affect in addition to the patient?
Issue 3: What kind of support and resources are needed or might be
released as the technology is put to use?
Issue 4: What kinds of changes does the use of the technology
generate in the patient's role in the major life areas?
Issue 5: What kind of changes does the implementation and use of
the technology mean for the patients physical and psychological
functioning in his or her major life areas?
9
EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu
Joint Action 2010–2012
Social aspects
Topic 2: Individual
Issue 6: How do patients and important others react and act
upon the technology?
Topic 3: Communication
Issue 7: What is patients' and important others’ knowledge and
understanding of the technology?
Issue 8: How is the information regarding the use of the
technology processed and exchanged?
Issue 9: What are the consequences in decision making?
10
EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu
Joint Action 2010–2012
How to get involved with
EUnetHTA?
• EUnetHTA Stakeholder Forum
• Public consultations on deliverables
and certain documents
• Targeted inquiries on specific subjects
emerging from the work performed in
the EUnetHTA JA Work Packages
• Stakeholder Involvement online area
within the EUnetHTA website will be
developed during 2010
11
EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu
Joint Action 2010–2012
EUnetHTA Collaboration:
how to ensure continuity?
• Focus on methodology but ALSO on a working process
(i.e. developing practical tools)
• Strong emphasis on the management and organisational
support structures for co-operation
• Stakeholder involvement, openness to dialogue and
inclusiveness
• Attention to the policy processes in European healthcare
• Continuous attention to delivering a unique and added
value to partners and users
12
EUnetHTA | European network for Health Technology Assessment | www.eunethta.eu
Joint Action 2010–2012